FDA Labeling Proposal Should Allow "Flexible" Warnings, Merck Tells Agency

Standardized headings in the "Warnings/Precautions" section of labeling would inappropriately limit manufacturer flexibility in communicating drug risk information, Merck said in comments on the agency's labeling rewrite proposed rule.